Regional anesthesia

Rate of occurrence of respiratory complications in patients who undergo shoulder arthroplasty with a continuous interscalene brachial plexus block and associated risk factors

Reg Anesth Pain MedPublished Retrospective cohort study

Authors' conclusion

Patient-related factors that can be measured preoperatively are associated with increased likelihood of respiratory complications after elective shoulder arthroplasty with CISB.

Study context

Population
Adults undergoing elective shoulder arthroplasty with continuous interscalene brachial plexus blocks (CISB)
Participants
1,025 shoulder arthroplasty cases
Outcome
Respiratory complications (none, mild, moderate, severe) and associated risk factors
Methodological detailssingle-institution
  • Single-institution

Main finding

As reported in the abstract

Any respiratory complication

Any respiratory complication

351

34%

Mild respiratory complications

279

27%

Moderate respiratory complications

61

6%

Severe respiratory complications

11

1%

Observational data: associations, not effects.

Further findings

Patient-related risk factors for respiratory complication (adjusted analysis)

OR (95% CI)
ASA Physical Status IIIAdjusted analysis1.69 (1.21–2.36)
AsthmaAdjusted analysis1.59 (1.07–2.37)
Congestive HFAdjusted analysis1.99 (1.19–3.33)
BMIAdjusted analysis1.06 (1.03–1.09)
AgeAdjusted analysis1.02 (1.00–1.04)
OutcomeOR (95% CI)P value
Patient-related risk factors for respiratory complication (adjusted analysis)Preoperative SpO2 (per 1% decrease) · 32% higher likelihood per 1% decrease · adjusted analysis1.32 (1.20–1.46)P < 0.001

Original publication

Rate of occurrence of respiratory complications in patients who undergo shoulder arthroplasty with a continuous interscalene brachial plexus block and associated risk factors. Reg Anesth Pain Med. Published 12 May 2023. doi:10.1136/rapm-2022-104264

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.